Cutting-edge Product Launches Bio-Rad Laboratories is consistently launching innovative products such as the ChemiDoc Go Imaging System and multiplex mutation detection tests, indicating a focus on cutting-edge solutions that can capture the interest of research and diagnostic labs looking for advanced technology.

Strategic Collaborations The collaboration agreement with Oncocyte Corporation to develop transplant monitoring products showcases Bio-Rad's strategic partnerships, presenting an opportunity for sales professionals to explore potential joint offerings and solutions to offer customers a comprehensive suite of products.

Investment Magnetism With recent investments totaling $4.05 million from Roubaix Capital LLC, Bio-Rad Laboratories is showing financial strength and attracting investor interest, signaling stability and potential growth prospects that can be leveraged by sales teams to build relationships and explore sales opportunities.

Expansive Product Portfolio The expansion of product lines with releases like StarBright Red Dyes and GraftAssure demonstrates Bio-Rad's wide-ranging portfolio catering to different research and diagnostic needs, providing sales teams with an array of products to suit various customer requirements and preferences.

Global Leader Status As a global leader with over 8,000 employees, Bio-Rad Laboratories commands a strong market presence and reputation, offering sales professionals an established brand to align with and potentially open doors to new clients seeking trusted and proven solutions in the biotechnology research industry.